No. HT942526TBIPHRPCTA · Defense Health Agency Contracting Activity - DHACA
DoW Traumatic Brain Injury and Psychological Health, Clinical Trial Award
Invitation only
“Invitation to Submit an Application: August 27, 2026” — From the announcement
- Award range
- Not specified
- Expected awards
- ~6
- Application deadline
- Oct 15, 2026
- Posted
- May 21, 2026
- Last verified
- 2 days ago
At a glance
AI summaryThis program funds clinical trials related to traumatic brain injury and psychological health, including studies of drugs, devices, diagnostics, therapies, behavioral strategies, prevention, treatment, rehabilitation, and health services research. Applicants must be U.S. Department of War organizations, including foreign or domestic, for-profit or nonprofit, and public or private entities; awards go to eligible organizations, not individuals. The award has two research levels: Level 1 for proof-of-principle pilot studies and phase 1/2 trials, and Level 2 for larger effectiveness trials, with total cost caps of $2.1 million and $4.1 million respectively and a maximum period of performance of 4 years. Cost sharing is not required, preliminary data and community-based participatory research are required, and the work must address at least one listed focus area for prevention or treatment of TBI or psychological health conditions.
AI-generated summary — verify against the announcement
What it funds
Official description from grants.gov
Summary: The fiscal year 2026 (FY26) Traumatic Brain Injury and Psychological Health Research Program (TBIPHRP) Clinical Trial Award (CTA) intends to support clinical trials with the potential to have a significant impact on psychological health conditions and/or traumatic brain injury (TBI) through clinical applications, including health care products, technologies and/or practice guidelines. Distinctive Features: Funding from this award mechanism must support a clinical trial. · Clinical trials may be designed to evaluate a wide range of interventions, including new drugs, biologics, medical devices, diagnostics, therapies and behavioral health strategies. · Preliminary data are required. · The inclusion of community-based participatory research (CBPR) approaches is required. · The CTA offers funding for two Research Levels. The applicant is responsible for selecting the Research Level based on the scope of the research. ○ Research Level 1: Supports proof-of-principle pilot studies, as well as phase 1 and phase 2 clinical trials. ○ Research Level 2: Supports larger-scale and advanced clinical trials that evaluate effectiveness in relevant patient populations. · Early-Career Investigator Partnering Option ( available for both Research Levels ): This option accommodates two Principal Investigators (PIs), one of which is an Early-Career Investigator. If recommended for funding, each PI will receive a separate award.
Who can apply
- Unrestricted
Program history
USASpending.govAssistance listing 12.420 · Military Medical Research and Development
Real awards this federal program has made — the whole assistance listing (12.420), not just this notice.
| Fiscal year | Awards | Median award | Middle half |
|---|---|---|---|
| FY 2026 (so far) | 374 | $934,195 | $559,998 – $1,477,811 |
| FY 2025 | 967 | $796,174 | $416,995 – $1,480,602 |
| FY 2024 | 1,097 | — | — |
| FY 2023 | 1,115 | — | — |
| FY 2022 | 1,186 | — | — |
| FY 2021 | 1,023 | — | — |
Dollar figures are based on the 1,000 most recent awards we store, not all 5,762 — award counts are complete.
- THE UNIVERISTY OF TEXAS M.D. ANDERSON CANCER CENTER $19,100,256 · FY 2025
- H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC. $18,696,738 · FY 2025
- UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE $10,606,583 · FY 2025
- SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH $10,500,000 · FY 2026
- UNIVERSITY OF VERMONT & STATE AGRICULTURAL COLLEGE $8,491,997 · FY 2025
Source: USASpending.gov · refreshed Aug 25, 2026